Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)
Zhejiang Provincial People's Hospital
Zhejiang Provincial People's Hospital
Albert Einstein College of Medicine
Capital Medical University
Zhejiang Provincial People's Hospital
Indiana University
Shanghai Pudong Hospital
ChineseAMS
Hebei Medical University Fourth Hospital
Cancer Trials Ireland
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Zhejiang Cancer Hospital
University of Sao Paulo General Hospital
University of Washington
Memorial Sloan Kettering Cancer Center
Hebei Medical University Fourth Hospital
University of Chicago
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
SCRI Development Innovations, LLC
University of Vermont
King Faisal Specialist Hospital & Research Center